Category Archives: Blog

‘Not time for protests’

Queensland Premier Annastacia Palaszczuk is under pressure to launch legal action to stop a planned mass protest in the heart of Brisbane on Saturday. At least 3000 people have shown their support on social media to take part in a rally on the Story Bridge, protesting against the treatment of asylum seekers held in a… Read More »

Coronavirus pandemic shows no sign of slowing across South America

Existing subscribers, please log in with your email address to link your account access. Paid annually by Credit Card Inclusive of applicable taxes (VAT) *Free gift is only available with quarterly and annual subscription purchases where subscription delivery is in the United Kingdom, USA, Canada, Australia, New Zealand or Euro area New Scientist – Health

Schools ‘must come before pubs and restaurants in future’

Schools should only close after pubs, restaurants and non-essential shops in any future lockdown, the children’s commissioner for England has said. Anne Longfield says children have a right to an education, must not be an “afterthought”, and that schools should be “first to open, last to close”. She says children play a smaller role in… Read More »

In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche’s Polivy

The FDA hasn’t specifically approved a therapy for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma after an initial line of therapy—until now. MorphoSys and Incyte’s Monjuvi—also known as tafasitamab—in combination with Celgene’s Revlimid now represents the first FDA-approved second-line regimen for DLBCL, the two companies said Friday. Because of Monjuvi’s importance… Read More »